GlassScriptPhysician profile
Michael Joseph J Thomas
NPI 1669433025
$1,789.19
in general payments reported to CMS, 2019-2025
15 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2021: $211 · 2022: $1,133 · 2023: $98.84 · 2024: $47.38 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $272.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $746.26 | 2022 | |
| Reshape Lifesciences INC. | $209.35 | 2021-2022 | |
| Ambu INC. | $164.14 | 2022 | |
| Aerin Medical INC. | $144.47 | 2019 | |
| Abbott Laboratories | $126.58 | 2025 | Proclaim |
| Takeda Pharmaceuticals U.S.A., INC. | $99.02 | 2021-2022 | |
| Novo Nordisk INC | $69.68 | 2021-2023 | Wegovy |
| Baxter Healthcare | $47.38 | 2024 | Seprafilm |
| Hologic Sales and Service, LLC | $39.15 | 2022 | |
| Organogenesis INC. | $30.88 | 2022-2023 | Puraply |
| Shire North American Group INC | $28.13 | 2019 | |
| Medtronic, INC. | $25.19 | 2023 | Signia |
| Davol INC. | $22.04 | 2023 | Phasix Mesh |
| Redhill Biopharma INC. | $20.51 | 2023 | |
| Currax Pharmaceuticals LLC | $16.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Joseph Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.